-
There could be a 2.5 times higher incidence of myocarditis in those receiving the Moderna vaccine compared to the Pfizer vaccine
–
US health officials are investigating reports that Moderna Inc’s covid-19 vaccine could be linked to an increased risk of rare heart disease in younger adults than previously thought, the Washington Post reported late Thursday, citing people familiar with the review.
The report quoted a source as saying that it was too early for regulators to come to a conclusion and that additional work was needed before any recommendations were made.
In June, health regulators added a warning to the literature accompanying vaccines of mRNAs produced by Moderna and Pfizer to point to the rare risk of cardiac inflammation that is seen mainly in young men. However, they said the benefit of the injections to prevent COVID-19 continued to outweigh the risks.
However, they said that the benefit of injections to prevent covid-19 he continued to overcome the risks.
Related news
There could be a 2.5 times higher incidence of myocarditis in those who receive the Moderna vaccine compared to the Pfizer vaccine, the Post said, citing a source.
Research focusing on Canadian data suggests that myocarditis risks may be especially higher for men under the age of 30, according to the report.
– .
